Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

por Savage, Paul D., Lovato, James, Brosnihan, K. Bridget, Miller, Antonius A., Petty, W. Jeffrey
Publicado 2016

Reverse translation of phase I biomarker findings links the activity of angiotensin-(1–7) to repression of hypoxia inducible factor-1α in vascular sarcomas

por Petty, W Jeffrey, Aklilu, Mebea, Varela, Victor A, Lovato, James, Savage, Paul D, Miller, Antonius A
Publicado 2012

Phase II trial of dose-dense chemotherapy followed by dose-intense erlotinib for patients with newly diagnosed metastatic non-small cell lung cancer

por PETTY, W. JEFFREY, LAUDADIO, JENNIFER, BRAUTNICK, LYNSAY, LOVATO, JAMES, DOTSON, TRAVIS, STREER, NATHAN P., WEAVER, KATHRYN E., MILLER, ANTONIUS A.
Publicado 2013

A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma

por Lycan, Thomas W., Pardee, Timothy S., Petty, William J., Bonomi, Marcelo, Alistar, Angela, Lamar, Zanetta S., Isom, Scott, Chan, Michael D., Miller, Antonius A., Ruiz, Jimmy
Publicado 2016